GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Khiron Life Sciences Corp (OTCPK:KHRWF) » Definitions » Total Inventories

Khiron Life Sciences (Khiron Life Sciences) Total Inventories : $7.36 Mil (As of Sep. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Khiron Life Sciences Total Inventories?

Khiron Life Sciences's total inventories for the quarter that ended in Sep. 2022 was $7.36 Mil. Khiron Life Sciences's average total inventories from the quarter that ended in Jun. 2022 to the quarter that ended in Sep. 2022 was $7.36 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Khiron Life Sciences's Net-Net Working Capital per share for the quarter that ended in Sep. 2022 was $N/A.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Khiron Life Sciences's Days Inventory for the three months ended in Sep. 2022 was 517.19.

Inventory Turnover measures how fast the company turns over its inventory within a year. Khiron Life Sciences's Inventory Turnover for the quarter that ended in Sep. 2022 was 0.18.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Khiron Life Sciences's Inventory-to-Revenue for the quarter that ended in Sep. 2022 was 2.90.


Khiron Life Sciences Total Inventories Historical Data

The historical data trend for Khiron Life Sciences's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Khiron Life Sciences Total Inventories Chart

Khiron Life Sciences Annual Data
Trend May12 May13 May14 May15 May16 May17 Dec18 Dec19 Dec20 Dec21
Total Inventories
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.18 0.73 6.51 7.39

Khiron Life Sciences Quarterly Data
Nov17 Feb18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Total Inventories Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.85 7.39 7.59 7.37 7.36

Khiron Life Sciences Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.


Khiron Life Sciences  (OTCPK:KHRWF) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Khiron Life Sciences's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2022 is

Net-Net Working Capital Per Share (Q: Sep. 2022 )
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1.453+0.75 * 3.284+0.5 * 7.357-8.508
-0-0)/0
=N/A

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Khiron Life Sciences's Days Inventory for the three months ended in Sep. 2022 is calculated as:

Days Inventory=Average Total Inventories (Q: Sep. 2022 )/Cost of Goods Sold (Q: Sep. 2022 )*Days in Period
=7.3625/1.299*365 / 4
=517.19

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Khiron Life Sciences's Inventory Turnover for the quarter that ended in Sep. 2022 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Sep. 2022 ) / Average Total Inventories (Q: Sep. 2022 )
=1.299 / 7.3625
=0.18

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Khiron Life Sciences's Inventory to Revenue for the quarter that ended in Sep. 2022 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Sep. 2022 ) / Revenue (Q: Sep. 2022 )
=7.3625 / 2.538
=2.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.


Khiron Life Sciences Total Inventories Related Terms

Thank you for viewing the detailed overview of Khiron Life Sciences's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.


Khiron Life Sciences (Khiron Life Sciences) Business Description

Traded in Other Exchanges
N/A
Address
2300 - 500 Burrard Street, Vancouver, BC, CAN, V6C 2B5
Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.